PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-5.43%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.59B
AUM Growth
+$2.59B
(-9.7%)
Cap. Flow
-$29.5M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
80
New
9
Increased
17
Reduced
15
Closed
11
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$80.4M |
| 2 |
Johnson & Johnson
JNJ
|
$46.1M |
| 3 |
Becton Dickinson
BDX
|
$41.9M |
| 4 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$34.1M |
| 5 |
Molina Healthcare
MOH
|
$24.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
$124M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$46.3M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$41.5M |
| 4 |
Neurocrine Biosciences
NBIX
|
$33.6M |
| 5 |
HCA Healthcare
HCA
|
$28.9M |
Sector Composition
| 1 | Healthcare | 95.79% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caribou Biosciences
CRBU
$176M
| $40.1M | 1.5% |
4,370,545
+278,236
| +7% | +$2.55M |
|
27
Edwards Lifesciences
EW
$47.7B
| $39.8M | 1.49% |
338,155
-35,337
| -9% | -$4.16M |
|
28
Icon
ICLR
$14B
| $38.5M | 1.44% |
158,183
| – | – |
|
29
Penumbra
PEN
$10.5B
| $37M | 1.38% |
166,719
-10,369
| -6% | -$2.3M |
|
30
Thermo Fisher Scientific
TMO
$183B
| $36.7M | 1.37% |
62,143
| – | – |
|
31
Waters Corp
WAT
$17.3B
| $36.5M | 1.37% |
117,634
| – | – |
|
32
Cardinal Health
CAH
$36B
| $36.3M | 1.36% |
639,783
| – | – |
|
33
Syndax Pharmaceuticals
SNDX
$1.39B
| $35.5M | 1.33% |
2,043,377
-60,135
| -3% | -$1.05M |
|
|
SRRA
34
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $34.1M | 1.27% |
+1,062,888
| New | +$34.1M |
|
35
McKesson
MCK
$85.9B
| $32.4M | 1.21% |
105,811
-71,189
| -40% | -$21.8M |
|
36
AstraZeneca
AZN
$255B
| $30M | 1.12% |
452,300
-333,448
| -42% | -$22.1M |
|
|
CTLT
37
DELISTED
CATALENT, INC.
CTLT
| $28.4M | 1.06% |
256,096
-70,604
| -22% | -$7.83M |
|
|
JNCE
38
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $27M | 1.01% |
3,972,868
| – | – |
|
|
KRTX
39
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $26.3M | 0.98% |
207,116
+30,025
| +17% | +$3.81M |
|
40
Cigna
CI
$80.2B
| $22.6M | 0.84% |
+94,135
| New | +$22.6M |
|
41
Elevance Health
ELV
$72.4B
| $21M | 0.79% |
42,734
| – | – |
|
42
Intellia Therapeutics
NTLA
$1.26B
| $20.9M | 0.78% |
287,909
+109,687
| +62% | +$7.97M |
|
43
Heron Therapeutics
HRTX
$204M
| $20.1M | 0.75% |
3,512,348
| – | – |
|
|
44
HCA Healthcare
HCA
$95.4B
| $20.1M | 0.75% |
80,128
-115,493
| -59% | -$28.9M |
|
45
DexCom
DXCM
$30.9B
| $18.9M | 0.71% |
37,021
+32,552
| +728% | +$16.7M |
|
|
ISEE
46
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $16.9M | 0.63% |
1,005,216
| – | – |
|
47
SOPHiA GENETICS
SOPH
$232M
| $15.6M | 0.58% |
2,014,024
+61,872
| +3% | +$478K |
|
48
Gilead Sciences
GILD
$140B
| $14.9M | 0.56% |
249,884
+172,891
| +225% | +$10.3M |
|
|
OSH
49
DELISTED
Oak Street Health, Inc.
OSH
| $14.1M | 0.53% |
523,644
+244,287
| +87% | +$6.57M |
|
|
AERI
50
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $9.91M | 0.37% |
1,088,566
| – | – |
|